• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • BioAsia 2023 to be held in February 24-26 in Telangana, India
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE
  • Event: Australia’s biggest week in biotech kicks off in Perth
  • $3 trillion growth reported for biotech sector in USA
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”
  • Vaccination, Rising Deaths, And The False Narrative
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka

Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka

0
By Biotech Express on February 26, 2022 Articles, Articles- Editorials, Biotech News

Drs. Krishna Ella and Suchitra Ella traveled through a rough road to bring Bharat Biotech to the forefront in vaccine production. Dr. Poonawala also made Serum Institute the major Vaccine Production unit in the world. I am happy to see that the Government of India honored them with Padma awards.

Ramareddy

As I recall one of his interview, he said the Indian biotech sector is today worth about USD 7 billion and according to the National Biotechnology Development Strategy, the target is to make it into a USD 100 billion industry by 2025, which he surely can support through his various initiatives as his company is doing great, said Prof Guntaka Ramareddy.

This year Dr Krishna Ella, Chairman, Hyderabad based Bharat Biotech along with Suchitra Ella, Director of the company and Dr Cyrus Poonawalla, founder of Pune-based Serum Institute of India (SII) are all set to be bestowed with Padma Awards. Both pharmaceutical firms – SII and Bharat Biotech – have led the country towards becoming self-sufficient in Covid-19 and other vaccines production and making them available at the lowest possible price in the world.

Dr Ella has joined an elite club of Padma awardee scientists like Varaprasad Reddy, Kiran Mazumdar Shaw who were not only the scientists but biopreneurs who started from scratch and touched skyline though their efforts, dedication and scientific temper.

I also remember how quickly he made Hepatitis-B vaccine immediately after us when I developed India’s first recombinant product and first Hepatitis b vaccine of India for Varaprasad Reddy (Padma Bhushan- 2005) who also did great work to start Shantha biotech in 1993 and with this product in hand becomes the first Indian company to develop, manufacture and market recombinant human healthcare products in India. In 1997, Shantha developed and commercialised India’s first r-DNA Hepatitis-B vaccine.

Adverse Events which are nearly absent in Covaxin as compared to other vaccines is a great advantage of scientific temper. Since he chose the dosage very low, it has very less chance of any adverse reaction unless a live virus enters the vial. On the other hand, it is proved after many reports that Moderna, Pfizer, Astrazeneca or SII’s, etc. vaccine have serious side effects as compared to covaxin. On this note Dr Ella deserves padma awards for his most safe and effective vaccine in times when an innovative and entrepreneurship approaches both were required.

It is also believed by some that committees does sometime makes mistakes while deciding awards, it is imperative to note that Dr Ella was mistakenly placed in Trade category though he was the chief scientist behind the vaccine development and thus would have come under Science or medicine category. There is a huge difference between the selection criteria of each of PADMA AWARDEE and there could be change in category, I believe the decision has come nice when the Indian govt. has recognized efforts of Dr Krishna Ella toward his scientific contribution in novel vaccine development.

About Suchitra Ella

Mrs. Suchitra Ella is the Joint Managing Director of Bharat Biotech, which she co-founded with his husband Dr. Krishna Ella in 1996. With experience in customer operations, finance, marketing and business development, Mrs. Ella is a strong pillar of support and guidance at Bharat Biotech, overseeing a wide range of operations in the company.

Mrs. Ella holds a BA in Economics and Social Sciences from the University of Madras. She followed this up with diploma in business development from UWCU—Madison, diploma in real estate management from University of South Carolina and post-graduate diploma in patent law from NALSAR—Hyderabad. Several awards have been conferred on her including the South Indian Business Achievers Award 2016, Zee TV Best Women Entrepreneur Award, SAARC Women Entrepreneur Award etc.

Mrs. Suchitra Ella is also the Chairperson of CII Indian Women Network. She serves on the Boards of ISB Well Wisher’s Trust and United Way Hyderabad—an International Charity Partner focused on social empowerment in local communities with focus on livelihoods, health and education. She was a former Board member of TTD. Mrs. Suchitra strongly believes in corporate citizenship and social responsibility. She spearheads the CSR initiatives of the company.

About Prof Ramareddy V Guntaka

Professor Guntaka is Emeritus Professor in Department of Microbiology, Immunology & Biochemistry, University of Tennessee, Health Sciences Center, Memphis, TN, USA and Chairman and Chief Scientist at Sudarshan Biotech Pvt Ltd., India.

• Prof Guntaka was one of the four members team that discovered Proto-oncogenes, genes implicated in causing cancer.
• Prof Guntaka was the first one to molecularly clone the entire genome of Rous Sarcoma Virus
• Prof Guntaka was the key scientist behind the successful development of the Recombinant Hepatitis B Vaccine.by Shantha Biotech
• Prof Guntaka was also the key scientist behind the successful development of interferon alpha used to treat hepatitis B infections.
• Prof Guntaka was also the first scientist to clone and study the complete genome of the Indian strains of Hepatitis C virus.

 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Praj Industries and ESIIC partner to further bioeconomy in Egypt

Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?

Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE

Leave A Reply Cancel Reply

Current Issue – October 2022
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
  • India’s Clinical Trial Registry might disappear soon and so the history of pharma record August 19, 2022
  • Nearly Half of Pregnant Women in Pfizer Trial Miscarried August 10, 2022
  • Researchers develop Cellulose shoes made by bacteria August 9, 2022
  • Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility August 5, 2022
  • CBI Arrests of CDSCO officials, a Biocon official & Intermediaries in an alleged bribery case exposed Corruption in Govt and Pharma sector July 27, 2022
  • We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO July 26, 2022
  • EVENT HIGHLIGHTS: Genome editing as a novel technology for sustainable development July 24, 2022
  • US Military Doctor Testifies under Oath That She Was ORDERED To ‘Cover up’ COVID Vaccine Injuries July 24, 2022
  • Climatic Effect on Marine Biodiversity and their impact on coral reefs July 23, 2022
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.